Brain Buffer System Overcomes Molecular Disturbances in Circadian Clock
By LabMedica International staff writers Posted on 30 Apr 2014 |

Image: Heat plots for microarray transcriptome experiment, of the genetically engineered Drosophila flies, indicating that the reduced amplitudes of the CLK-protein-driven circadian transcription oscillations (CTOs) leads to genome-wide reductions in CTO amplitudes, not only of the direct CLK-driven transcripts (Photo courtesy of Prof. Kadener, Hebrew University - Jerusalem, Israel, and PLOS Genetics).
New evidence has been found for neuronal network communication that helps create a behavioral buffer in the brain to overcome certain disturbances in the molecular level circadian clock rhythms.
Circadian clocks time the sleep/wake cycles as well as many other physiological and cellular pathways to daily 24 hour rhythms. In Drosophila, CLOCK (CLK) and CYCLE (CYC) proteins initiate the circadian system by promoting rhythmic transcription of hundreds of genes. Abolishment of circadian transcriptional oscillations (CTOs) has been shown to abolish circadian function. However, previous studies used manipulations in which the abolishment of the CTOs was very dramatic and involved strong up- or down-regulation of circadian genes.
In this study, a research team led by Sebastian Kadener, assistant professor at the Hebrew University of Jerusalem (Israel), used an innovative genetic approach that enabled them to generate Drosophila melanogaster fruit flies in which the amplitude of CLK-driven CTOs was reduced in a controlled way, either partially (approx. 60%) or strongly (90%). To the best of their knowledge, this is the first time CTOs have been partially damped in a living organism and their role assessed comprehensively.
The researchers postulated that in the brain, communication among the circadian neuronal groups can compensate for the dampened CTOs. This is not surprising, as results from studies on locomotor activity patterns in mammals with core clock protein mutations are among the same lines. However, in mammals the molecular machinery that drives circadian rhythms in the central versus the peripheral oscillators differs, whereas this does not seem to be the case in flies. Yet, in this study, the partial decrease in the amplitude of CTOs led to impaired function of circadian outputs in peripheral functions but did not significantly affect circadian locomotor behavior. This suggests that the clock in the brain has a specific compensatory mechanism. Moreover, flies with reduced CTOs that also had impaired circadian neuronal communication displayed aberrant circadian behavior rhythms.
The partially reduced CTOs led to low amplitude circadian protein oscillations (CPOs) that were not sufficient to drive outputs of peripheral oscillators, while circadian rhythms in locomotor activity were resistant to these partial reductions. This resilience of the brain oscillator was found to depend on communication among circadian neurons in the brain. Indeed, the capacity of the brain oscillator to overcome the low amplitude CTOs depends on the action of the neuropeptide PDF and on the pdf-expressing cells having equal or higher amplitude of CTOs than the rest of the circadian neuronal groups in the brain.
These findings support the idea of network buffering mechanisms that allows the brain to drive robust behavioral circadian rhythms even with low amplitude molecular oscillations. Therefore, in addition to revealing the importance of high amplitude CTOs for cell-autonomous circadian timekeeping, this work demonstrates that the brain's circadian neuronal network has an essential system that protects against disturbances in circadian transcription in the brain.
The study, by Weiss R. et al., was described in the journal PLOS Genetics, published April 3, 2014.
Related Links:
Hebrew University of Jerusalem
Circadian clocks time the sleep/wake cycles as well as many other physiological and cellular pathways to daily 24 hour rhythms. In Drosophila, CLOCK (CLK) and CYCLE (CYC) proteins initiate the circadian system by promoting rhythmic transcription of hundreds of genes. Abolishment of circadian transcriptional oscillations (CTOs) has been shown to abolish circadian function. However, previous studies used manipulations in which the abolishment of the CTOs was very dramatic and involved strong up- or down-regulation of circadian genes.
In this study, a research team led by Sebastian Kadener, assistant professor at the Hebrew University of Jerusalem (Israel), used an innovative genetic approach that enabled them to generate Drosophila melanogaster fruit flies in which the amplitude of CLK-driven CTOs was reduced in a controlled way, either partially (approx. 60%) or strongly (90%). To the best of their knowledge, this is the first time CTOs have been partially damped in a living organism and their role assessed comprehensively.
The researchers postulated that in the brain, communication among the circadian neuronal groups can compensate for the dampened CTOs. This is not surprising, as results from studies on locomotor activity patterns in mammals with core clock protein mutations are among the same lines. However, in mammals the molecular machinery that drives circadian rhythms in the central versus the peripheral oscillators differs, whereas this does not seem to be the case in flies. Yet, in this study, the partial decrease in the amplitude of CTOs led to impaired function of circadian outputs in peripheral functions but did not significantly affect circadian locomotor behavior. This suggests that the clock in the brain has a specific compensatory mechanism. Moreover, flies with reduced CTOs that also had impaired circadian neuronal communication displayed aberrant circadian behavior rhythms.
The partially reduced CTOs led to low amplitude circadian protein oscillations (CPOs) that were not sufficient to drive outputs of peripheral oscillators, while circadian rhythms in locomotor activity were resistant to these partial reductions. This resilience of the brain oscillator was found to depend on communication among circadian neurons in the brain. Indeed, the capacity of the brain oscillator to overcome the low amplitude CTOs depends on the action of the neuropeptide PDF and on the pdf-expressing cells having equal or higher amplitude of CTOs than the rest of the circadian neuronal groups in the brain.
These findings support the idea of network buffering mechanisms that allows the brain to drive robust behavioral circadian rhythms even with low amplitude molecular oscillations. Therefore, in addition to revealing the importance of high amplitude CTOs for cell-autonomous circadian timekeeping, this work demonstrates that the brain's circadian neuronal network has an essential system that protects against disturbances in circadian transcription in the brain.
The study, by Weiss R. et al., was described in the journal PLOS Genetics, published April 3, 2014.
Related Links:
Hebrew University of Jerusalem
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more
New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
Drug-induced kidney injury, also known as nephrotoxicity, is a prevalent issue in clinical practice, occurring when specific medications at certain doses cause damage to the kidneys. Nephrotoxicity can... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more